National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 267475

History of Changes from the VAERS Wayback Machine

First Appeared on 12/30/2006

VAERS ID: 267475
Age:26.0
Gender:Female
Location:New York
Vaccinated:2006-10-24
Onset:2006-10-25
Submitted:2006-11-14
Entered:2006-11-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE - / 2 - / -
HPV4: HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE, QUADRIVALENT (GARDASIL) / MERCK & CO. INC. 0954F / 0 - / IM

Administered by: Other      Purchased by: Unknown
Symptoms: Vision blurred

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ZITHROMAX
Current Illness:
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type':

Write-up:Initial and follow-up information has been received from a physician concerning a 26 year old female with no other pertinent medical history and no known allergies or adverse drug reactions reported. On 24-OCT-2006 the patient was vaccinated intramuscular"ly in the deltoid with the first /"1 vial/" dose of GARDASIL (lot #653938/0954F). Concomitant therapy included azithromycin (ZITHROMAX). It was reported that on 24-OCT-2006, the patient had been vaccinated with the third dose of TWINRIX. On 25-OCT-2006, /


Changed on 12/8/2009

VAERS ID: 267475 Before After
Age:26.0
Gender:Female
Location:New York
Vaccinated:2006-10-24
Onset:2006-10-25
Submitted:2006-11-14
Entered:2006-11-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE GLAXOSMITHKLINE BIOLOGICALS - / 2 - / -
HPV4: HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE, QUADRIVALENT (GARDASIL) HPV (GARDASIL) / MERCK & CO. INC. 0954F / 0 - / IM

Administered by: Other      Purchased by: Unknown Other
Symptoms: Vision blurred

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ZITHROMAX
Current Illness:
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type': (blank) WAES0611USA00528

Write-up:Initial and follow-up information has been received from a physician concerning a 26 year old female with no other pertinent medical history and no known allergies or adverse drug reactions reported. On 24-OCT-2006 the patient was vaccinated intramuscular"ly intramuscularly in the deltoid with the first /"1 vial/" "1 vial" dose of GARDASIL (lot #653938/0954F). Concomitant therapy included azithromycin (ZITHROMAX). It was reported that on 24-OCT-2006, the patient had been vaccinated with the third dose of TWINRIX. On 25-OCT-2006, / "within a day after immunization," the patient experienced blurry vision in both eyes. The patient sought unspecified medical attention. The patient was told by the physician to come to the office to be evaluated but had not. As of 02-NOV-2006, nine days after receiving GARDASIL, the physician reported that the blurred vision was "getting much better." Additional information has been requested.


Changed on 3/14/2014

VAERS ID: 267475 Before After
Age:26.0
Gender:Female
Location:New York
Vaccinated:2006-10-24
Onset:2006-10-25
Submitted:2006-11-14
Entered:2006-11-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 - UN / - UN
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0954F / 0 - UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Vision blurred

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ZITHROMAX
Current Illness:
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type': WAES0611USA00528

Write-up:Initial and follow-up information has been received from a physician concerning a 26 year old female with no other pertinent medical history and no known allergies or adverse drug reactions reported. On 24-OCT-2006 the patient was vaccinated intramuscularly in the deltoid with the first "1 vial" dose of GARDASIL (lot #653938/0954F). Concomitant therapy included azithromycin (ZITHROMAX). It was reported that on 24-OCT-2006, the patient had been vaccinated with the third dose of TWINRIX. On 25-OCT-2006, "within a day after immunization," the patient experienced blurry vision in both eyes. The patient sought unspecified medical attention. The patient was told by the physician to come to the office to be evaluated but had not. As of 02-NOV-2006, nine days after receiving GARDASIL, the physician reported that the blurred vision was "getting much better." Additional information has been requested.


Changed on 6/14/2014

VAERS ID: 267475 Before After
Age:26.0
Gender:Female
Location:New York
Vaccinated:2006-10-24
Onset:2006-10-25
Submitted:2006-11-14
Entered:2006-11-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 UN / UN
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0954F / 0 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Vision blurred

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ZITHROMAX
Current Illness:
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type': WAES0611USA00528

Write-up:Initial and follow-up information has been received from a physician concerning a 26 year old female with no other pertinent medical history and no known allergies or adverse drug reactions reported. On 24-OCT-2006 the patient was vaccinated intramuscularly in the deltoid with the first "1 vial" dose of GARDASIL (lot #653938/0954F). Concomitant therapy included azithromycin (ZITHROMAX). It was reported that on 24-OCT-2006, the patient had been vaccinated with the third dose of TWINRIX. On 25-OCT-2006, "within a day after immunization," the patient experienced blurry vision in both eyes. The patient sought unspecified medical attention. The patient was told by the physician to come to the office to be evaluated but had not. As of 02-NOV-2006, nine days after receiving GARDASIL, the physician reported that the blurred vision was "getting much better." Additional information has been requested.


Changed on 3/14/2015

VAERS ID: 267475 Before After
Age:26.0
Gender:Female
Location:New York
Vaccinated:2006-10-24
Onset:2006-10-25
Submitted:2006-11-14
Entered:2006-11-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPAB: HEP A + HEP B (TWINRIX) / GLAXOSMITHKLINE BIOLOGICALS - / 2 UN / UN
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0954F / 0 UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Vision blurred

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: ZITHROMAX
Current Illness:
Preexisting Conditions: NONE
Diagnostic Lab Data: NONE
CDC 'Split Type': WAES0611USA00528

Write-up:Initial and follow-up information has been received from a physician concerning a 26 year old female with no other pertinent medical history and no known allergies or adverse drug reactions reported. On 24-OCT-2006 the patient was vaccinated intramuscularly in the deltoid with the first "1 vial" dose of GARDASIL (lot #653938/0954F). Concomitant therapy included azithromycin (ZITHROMAX). It was reported that on 24-OCT-2006, the patient had been vaccinated with the third dose of TWINRIX. On 25-OCT-2006, "within a day after immunization," the patient experienced blurry vision in both eyes. The patient sought unspecified medical attention. The patient was told by the physician to come to the office to be evaluated but had not. As of 02-NOV-2006, nine days after receiving GARDASIL, the physician reported that the blurred vision was "getting much better." Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=267475&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166